title: Comparative analysis of SV40 17kT and LT function in vivo demonstrates that LT's C-terminus re-programs hepatic gene expression and is necessary for tumorigenesis in the liver.
abstract: Transformation by Simian Virus 40 (SV40) large T antigen (LT) is mediated in large part by its interaction with a variety of cellular proteins at distinct binding domains within LT. While the interaction of LT's N-terminus with the tumor suppressor Rb is absolutely required for LT-dependent transformation, the requirement for the interaction of LT's C-terminus with p53 is less clear and cell- and context-dependent. Here, we report a line of transgenic mice expressing a doxycycline-inducible liver-specific viral transcript that produces abundant 17kT, a naturally occurring SV40 early product that is co-linear with LT for the first 131 amino acids and that binds to Rb, but not p53. Comparative analysis of livers of transgenic mice expressing either 17kT or full length LT demonstrates that 17kT stimulates cell proliferation and induces hepatic hyperplasia but is incapable of inducing hepatic dysplasia or promoting hepatocarcinogenesis. Gene expression profiling demonstrates that 17kT and LT invoke a set of shared molecular signatures consistent with the action of LT's N-terminus on Rb-E2F-mediated control of hepatocyte transcription. However, 17kT also induces a unique set of genes, many of which are known transcriptional targets of p53, while LT actively suppresses them. LT also uniquely deregulates the expression of a subset of genes within the imprinted network and rapidly re-programs hepatocyte gene expression to a more fetal-like state. Finally, we provide evidence that the LT/p53 complex provides a gain-of-function for LT-dependent transformation in the liver, and confirm the absolute requirement for LT's C-terminus for liver tumor development by demonstrating that phosphatase and tensin homolog (PTEN)-deficiency readily cooperates with LT, but not 17kT, for tumorigenesis. These results confirm independent and inter-dependent functions for LT's N- and C-terminus and emphasize differences in the requirements for LT's C-terminus in cell-type dependent transformation.
authors.affiliation: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Comerford
authors.forename: N
authors.initials: N
authors.lastname: Schultz
authors.forename: E A
authors.initials: EA
authors.lastname: Hinnant
authors.forename: S
authors.initials: S
authors.lastname: Klapproth
authors.forename: R E
authors.initials: RE
authors.lastname: Hammer
references.citation: Mol Cell Biol. 1986 Oct;6(10):3531-6
references.pmid: 3025598
references.citation: Science. 2008 Aug 22;321(5892):1084-5
references.pmid: 18719283
references.citation: Cancer Res. 1991 May 15;51(10):2611-20
references.pmid: 1708696
references.citation: Biochem Biophys Res Commun. 2006 Dec 29;351(4):820-4
references.pmid: 17097610
references.citation: J Virol. 1994 Mar;68(3):1334-41
references.pmid: 8107198
references.citation: J Biol Chem. 2001 Nov 9;276(45):42057-62
references.pmid: 11572852
references.citation: J Virol. 2009 Jan;83(1):117-27
references.pmid: 18922873
references.citation: Nature. 1997 Jun 19;387(6635):823-7
references.pmid: 9194565
references.citation: Stem Cells. 2007 Oct;25(10):2419-29
references.pmid: 17585168
references.citation: Oncogene. 1998 May 7;16(18):2395-401
references.pmid: 9620557
references.citation: J Clin Invest. 1997 Dec 1;100(11):2697-713
references.pmid: 9389733
references.citation: Hepatology. 2007 Aug;46(2):535-47
references.pmid: 17508344
references.citation: J Virol. 2009 Oct;83(19):10106-18
references.pmid: 19625393
references.citation: Cell. 1988 Jul 15;54(2):275-83
references.pmid: 2839300
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2082-7
references.pmid: 14769918
references.citation: Oncogene. 2000 Jul 20;19(31):3498-507
references.pmid: 10918608
references.citation: Oncogene. 1993 Oct;8(10):2805-12
references.pmid: 8378089
references.citation: J Virol. 2000 Jan;74(2):864-74
references.pmid: 10623749
references.citation: Mol Cell Biol. 1997 Aug;17(8):4761-73
references.pmid: 9234732
references.citation: Genesis. 2006 Jun;44(6):287-96
references.pmid: 16786601
references.citation: Genes Cancer. 2011 Apr;2(4):404-19
references.pmid: 21779509
references.citation: Semin Cancer Biol. 2001 Feb;11(1):23-30
references.pmid: 11243896
references.citation: Biol Chem. 1999 Feb;380(2):203-11
references.pmid: 10195427
references.citation: Stem Cells Dev. 2011 Dec;20(12):2177-88
references.pmid: 21361791
references.citation: Oncogene. 2008 Oct 23;27(49):6334-46
references.pmid: 18663356
references.citation: Cell Death Differ. 2006 Jun;13(6):1027-36
references.pmid: 16557269
references.citation: Virology. 2009 Feb 20;384(2):294-303
references.pmid: 19070883
references.citation: Oncogene. 2003 Apr 24;22(16):2515-30
references.pmid: 12717428
references.citation: Semin Liver Dis. 2006 Nov;26(4):385-90
references.pmid: 17051452
references.citation: J Biol Chem. 2005 Nov 25;280(47):39152-60
references.pmid: 16203738
references.citation: Cell. 2005 May 6;121(3):465-77
references.pmid: 15882627
references.citation: Nat Cell Biol. 2011 Oct 23;13(11):1353-60
references.pmid: 22020437
references.citation: Semin Cancer Biol. 2009 Aug;19(4):229-35
references.pmid: 19505650
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):947-52
references.pmid: 14732683
references.citation: Genes Dev. 1992 Oct;6(10):1886-98
references.pmid: 1398068
references.citation: Virology. 2003 Oct 10;315(1):148-58
references.pmid: 14592767
references.citation: Proc Natl Acad Sci U S A. 1978 Mar;75(3):1274-8
references.pmid: 206891
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12201-6
references.pmid: 14526100
references.citation: J Virol. 2009 Sep;83(18):9521-31
references.pmid: 19570859
references.citation: Cell. 2007 Sep 21;130(6):1120-33
references.pmid: 17889654
references.citation: Genesis. 2000 Feb;26(2):149-50
references.pmid: 10686614
references.citation: Hum Gene Ther. 2002 Jan 20;13(2):199-210
references.pmid: 11812277
references.citation: Oncogene. 1998 Sep 10;17(10):1253-9
references.pmid: 9771968
references.citation: J Cell Biol. 2004 Nov 22;167(4):673-86
references.pmid: 15557119
references.citation: J Virol. 2005 Jun;79(12):7492-502
references.pmid: 15919904
references.citation: Science. 2008 Aug 22;321(5892):1086-8
references.pmid: 18719284
references.citation: Virology. 2008 Aug 1;377(2):227-32
references.pmid: 18570961
references.citation: Genome Biol. 2007;8(3):R39
references.pmid: 17367534
references.citation: Stem Cells. 2008 Aug;26(8):1998-2005
references.pmid: 18511599
references.citation: J Virol. 1997 Jul;71(7):5620-3
references.pmid: 9188637
references.citation: Genesis. 2002 Feb;32(2):148-9
references.pmid: 11857804
references.citation: Gastroenterology. 2011 Oct;141(4):1439-50
references.pmid: 21704587
references.citation: Semin Cancer Biol. 2009 Aug;19(4):218-28
references.pmid: 19505649
references.citation: Virology. 2009 Mar 30;386(1):183-91
references.pmid: 19201438
references.citation: Mol Cell Biol. 1996 Jul;16(7):3454-64
references.pmid: 8668161
references.citation: J Clin Invest. 2004 Jun;113(12):1774-83
references.pmid: 15199412
references.citation: Oncogene. 2005 Nov 21;24(52):7729-45
references.pmid: 16299533
references.citation: EMBO J. 1996 May 1;15(9):2236-48
references.pmid: 8641289
references.citation: J Virol. 2004 Aug;78(15):8245-53
references.pmid: 15254196
references.citation: EMBO J. 1993 Dec;12(12):4739-46
references.pmid: 8223482
references.citation: Stem Cells. 2007 Oct;25(10):2476-87
references.pmid: 17641245
references.citation: Genes Dev. 2004 Jun 1;18(11):1305-16
references.pmid: 15175262
references.citation: J Virol. 2006 May;80(9):4292-303
references.pmid: 16611888
references.citation: Cancer Res. 2005 Jun 1;65(11):4568-77
references.pmid: 15930274